Revenue from Contract with Customer, Excluding Assessed Tax of Outlook Therapeutics, Inc. from 30 Jun 2025 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Outlook Therapeutics, Inc. annual and quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 30 Jun 2025 to 30 Sep 2025.
  • Outlook Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Jun 2025 was $1,505,322.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)

Outlook Therapeutics, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,413,535 01 Oct 2024 30 Sep 2025 10-K 19 Dec 2025 2025 FY

Outlook Therapeutics, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,505,322 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.